Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Changing the Paradigm in Hemophilia Care: Extended Half-Life Products (rFVIIIFc and rFIXFc)

Louis M. Aledort, MD, Nisha Jain, MBBS,MD, Nanxin Li, Sangeeta Krishnan, PharmD, Benjamin Hagberg, Jun Su, MD

Blood (2018) 132 (Supplement 1): 3514.

https://doi.org/10.1182/blood-2018-99-114905

Published: 2018

Journal Articles

Hemophilia Lend-Lease Program in Italy Successfully Meets Albania Factor Needs

Louis M. Aledort, MD, Michele De Luca, MD, Maria Jose Caldes Pinilla, Alberto Zanobini, Simona Carli, Anila Godo, Ogerta Manastirliu, Gentian Kolaj, Tatiana Caja, Vera Neziri

Blood (2016) 128 (22): 5916.

https://doi.org/10.1182/blood.V128.22.5916.5916

Published: 2016

Journal Articles

Platelet Function Disorders in Bleeding Patients without Other Coagulopathies

Francine R. Dembitzer, MD, Ellinor I.B. Peerschke, PhD, Caroline Cromwell, MD, Xiaofei Zhang, MD, PhD, Louis M. Aledort, MD

Blood (2015) 126 (23): 4650.

https://doi.org/10.1182/blood.V126.23.4650.4650

Published: 2015

Journal Articles

Congenital Thrombotic Thrombocytopenia Purpura - Safer Treatment with Plasma-Derived Viral-Attenuated Clotting Factor

Louis M. Aledort, MD, Lisa Boggio, MD, Joanna A. Davis, MD, Cynthia Gauger, MD, Nathan L. Kobrinsky, MD FRCP, Anita Rajasekhar, MD MS, Ralph Shapiro, MD, Marcela Torres, MD, Paula J. Ulsh, RN, BSN

Blood (2015) 126 (23): 3459.

https://doi.org/10.1182/blood.V126.23.3459.3459

Published: 2015

Journal Articles

Hemophilia Prophylaxis No Longer Just for Children without Inhibitors - Increasing Use of Prophylaxis in Other Groups (children with inhibitors and adults with and without inhibitors)

Manuel Carcao, MD, Maria L. Avila, MD, Victor S. Blanchette, MD FRCP, Elena Santagostino, MD PhD, Carmen Escuriola-Ettingshausen, MD PhD, Cindy A. Leissinger, MD, Thierry Lambert, Louis M. Aledort, MD

Blood (2015) 126 (23): 3535.

https://doi.org/10.1182/blood.V126.23.3535.3535

Published: 2015

Journal Articles

A US Pilot Data Registry for Patients with Congenital Thrombotic Thombocytopenic Purpura (CTTP): The Unexpected Results

Tammuella Singleton, MD, Louis M. Aledort, MD, Leissinger Cindy, MD, Paula Ulsh, BSN, Garrett E. Bergman, MD MBA

Blood (2014) 124 (21): 5036.

https://doi.org/10.1182/blood.V124.21.5036.5036

Published: 2014

Journal Articles

A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia

James B. Bussel, David J. Kuter, Louis M. Aledort, Craig M. Kessler, Adam Cuker, Kelly B. Pendergrass, Shande Tang, Joe McIntosh

Blood (2014) 123 (25): 3887–3894.

https://doi.org/10.1182/blood-2013-07-514398

Published: 2014

Includes: Supplemental data

Journal Articles

The Effect of a Specialized Case Management Program On Factor Replacement Use On Patients with Bleeding Disorders

Anthony Bonagura, MD, Eileen Decristofano, RN, Roberta Faulds, RN, Keryn M Rich, RN, BSN, CCM, Judith Schiavone-Grosser, RN-BC BSN CCM, Carol A Deniz, RN, Louis M. Aledort, MD

Blood (2012) 120 (21): 4257.

https://doi.org/10.1182/blood.V120.21.4257.4257

Published: 2012

Journal Articles

Rescue and Primary ITI in Children and Adults with a Single FVIII/VWF Product

Louis M. Aledort, MD, Johannes Oldenburg, MD, Elena Santagostino, MD, PhD, Victor Jimenez Yuste, MD PhD

Blood (2012) 120 (21): 1174.

https://doi.org/10.1182/blood.V120.21.1174.1174

Published: 2012

Journal Articles

Winrho: Safety and Efficacy during Pregnancy

Caroline Cromwell, MD, Michael Tarantino, MD, Louis M. Aledort, MD

Blood (2008) 112 (11): 4543.

https://doi.org/10.1182/blood.V112.11.4543.4543

Published: 2008

Journal Articles

TPO Mimetics: Can More Than One Agent Be Used in a Patient?

Caroline Cromwell, MD, Louis M. Aledort, MD

Blood (2008) 112 (11): 4550.

https://doi.org/10.1182/blood.V112.11.4550.4550

Published: 2008

Journal Articles

Evaluation of Bleeding and Thrombotic Events during Long-Term Use of Romiplostim in Patients with Chronic Immune Thrombocytopenic Purpura.

Michael Tarantino, MD, Usha Sunkara, MD, James George, MD, Louis M. Aledort, MD, Matthew Guo, PhD, Dietmar Berger, MD, PhD, Terry Gernsheimer, MD

Blood (2008) 112 (11): 3422.

https://doi.org/10.1182/blood.V112.11.3422.3422

Published: 2008

Journal Articles

Hemophilia lives: the impact of prophylaxis

Louis M. Aledort

Blood (2008) 111 (4): 1752–1753.

https://doi.org/10.1182/blood-2007-11-123760

Published: 2008

Journal Articles

Hemophilia Treatment - A Model for Appropriate Cost Control.

Louis M. Aledort, MD, James G. Coates, MD

Blood (2007) 110 (11): 3942.

https://doi.org/10.1182/blood.V110.11.3942.3942

Published: 2007

Journal Articles

Evaluation of AMG 531 Efficacy in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura (ITP) in a Randomized Placebo-Controlled Phase 3 Study.

Terry B. Gernsheimer, Vinod Pullarkat, Francis M. Senecal, Louis M. Aledort, Craig M. Kessler, Miguel A. Sanz, Howard A. Liebman, Frank T. Slovick, Reggie Kelly, Matthew Guo, Janet Nichol

Blood (2007) 110 (11): 2.

https://doi.org/10.1182/blood.V110.11.2.2

Published: 2007

Journal Articles

Evaluation of AMG 531 Efficacy in Nonsplenectomized Patients with Chronic Immune Thrombocytopenic Purpura (ITP) in a Randomized Placebo-Controlled Phase 3 Study.

David J. Kuter, James B. Bussel, Francis M. Senecal, Louis M. Aledort, Craig M. Kessler, Miguel A. Sanz, Howard A. Liebman, Frank T. Slovick, Reggie Kelly, Matthew Guo, Janet L. Nichol

Blood (2007) 110 (11): 565.

https://doi.org/10.1182/blood.V110.11.565.565

Published: 2007

Journal Articles

The Clinical and Direct Medical Cost Burden of Splenectomy among Managed Care Patients with Chronic Immune Thrombocytopenic Purpura (ITP).

Louis M. Aledort, Roger M. Lyons, Gary Okano, Joseph Leveque

Blood (2006) 108 (11): 5536.

https://doi.org/10.1182/blood.V108.11.5536.5536

Published: 2006

Journal Articles

Retrospective Matched Cohort Study of Immune Thrombocytopenic Purpura (ITP): Complications Related to Corticosteroid (CS) Use.

Louis M. Aledort, Roger M. Lyons, Gary Okano, Joseph Leveque

Blood (2006) 108 (11): 3295.

https://doi.org/10.1182/blood.V108.11.3295.3295

Published: 2006

Journal Articles

Is Homozygosity for the MTHFR C677T Mutation a Risk Factor for Miscarriage? — Likely.

Ivy Altomare, MD, Louis M. Aledort, MD

Blood (2006) 108 (11): 4079.

https://doi.org/10.1182/blood.V108.11.4079.4079

Published: 2006

Journal Articles

Do hemophilia carriers bleed? Yes.

Louis M. Aledort

Blood (2006) 108 (1): 6.

https://doi.org/10.1182/blood-2006-04-016162

Published: 2006

NARROW

Changing the Paradigm in Hemophilia Care: Extended Half-Life Products (rFVIIIFc and rFIXFc)

Hemophilia Lend-Lease Program in Italy Successfully Meets Albania Factor Needs

Platelet Function Disorders in Bleeding Patients without Other Coagulopathies

Congenital Thrombotic Thrombocytopenia Purpura - Safer Treatment with Plasma-Derived Viral-Attenuated Clotting Factor

Hemophilia Prophylaxis No Longer Just for Children without Inhibitors - Increasing Use of Prophylaxis in Other Groups (children with inhibitors and adults with and without inhibitors)

A US Pilot Data Registry for Patients with Congenital Thrombotic Thombocytopenic Purpura (CTTP): The Unexpected Results

A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia

The Effect of a Specialized Case Management Program On Factor Replacement Use On Patients with Bleeding Disorders

Rescue and Primary ITI in Children and Adults with a Single FVIII/VWF Product

Winrho: Safety and Efficacy during Pregnancy

TPO Mimetics: Can More Than One Agent Be Used in a Patient?

Evaluation of Bleeding and Thrombotic Events during Long-Term Use of Romiplostim in Patients with Chronic Immune Thrombocytopenic Purpura.

Hemophilia lives: the impact of prophylaxis

Hemophilia Treatment - A Model for Appropriate Cost Control.

Evaluation of AMG 531 Efficacy in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura (ITP) in a Randomized Placebo-Controlled Phase 3 Study.

Evaluation of AMG 531 Efficacy in Nonsplenectomized Patients with Chronic Immune Thrombocytopenic Purpura (ITP) in a Randomized Placebo-Controlled Phase 3 Study.

The Clinical and Direct Medical Cost Burden of Splenectomy among Managed Care Patients with Chronic Immune Thrombocytopenic Purpura (ITP).

Retrospective Matched Cohort Study of Immune Thrombocytopenic Purpura (ITP): Complications Related to Corticosteroid (CS) Use.

Is Homozygosity for the MTHFR C677T Mutation a Risk Factor for Miscarriage? — Likely.

Do hemophilia carriers bleed? Yes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only